ESMO Daily Reporter
The ESMO Daily Reporter is the official ESMO newspaper providing live reporting, highlights, critical insights on data presented at ESMO congresses, and expert opinions on controversial topics.
Newsroom
Read the latest news and updates from ESMO and the oncology community
Resources for Press Representatives
For press representatives interested in reporting on cancer issues, check for the latest press releases and press briefings, abstract announcements, embargo policies, meeting information and tailored resources.
Society Updates
In Memory of Maurice Schneider: Pioneering Oncologist and ESMO Co-founder
It is with great sadness that ESMO has learnt of the passing of Maurice Schneider, one of the Society’s co-founders
Safeguarding Innovation in Cancer Research: ESMO’s Commitment to Supporting Intelligent Regulation
At a time when innovation is more critical than ever in oncology, ESMO is determined to ensure that regulatory developments support, rather than hinder, cancer research in Europe
Oncology News
FDA Approves Pembrolizumab for HER2 Positive Gastric or Gastro-oesophageal Junction Adenocarcinoma Expressing PD-L1 (CPS ≥1)
Evidence for efficacy is based on the results from the KEYNOTE-811 study
EMA Recommends Granting a Conditional Marketing Authorisation for Linvoseltamab
It is intended for the treatment of patients with relapsed and refractory multiple myeloma
Adding Pembrolizumab to Docetaxel Does Not Significantly Improve Outcomes in Patients with Previously Treated mCRPC
Findings from the KEYNOTE-921 study